On 12th September 2022, Merck Sharp & Dohme (MSD) convened a roundtable bringing together some of the country’s leading healthcare professionals. The purpose of the roundtable was to provide a forum to discuss the ways in which HCV case finding could be improved and increase the uptake and use of the Patient Search Identification (PSI) software.
The PSI software is a case-finding tool which searches for coded HCV risk factors in patient records in primary care settings to identify potentially at-risk patients that should be reviewed and, if appropriate, tested.
‘Driving Elimination through HCV Case Finding in Primary Care’ shines a light on the best approaches to empowering Healthcare Professionals and third sector organisations with the tools needed to tackle HCV rates in England. The convened experts came up with eight recommendations which would bring improvements to the pathway, which are summarised in this report.